🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Gastric Cancer Stage IV

Radiotherapy + Chemoimmunotherapy Followed by Surgery in Patients With Limited Metastatic Gastric or GEJ Cancer NCT06121700Phase 21 site📍 Shanghai Fudan University · Tests: Radiotherapy targeted to the primary lesion, Radiotherapy targeted to the metastatic lesions, Anti-PD-1 monoclonal anti… Iparomlimab and Tuvonralimab (QL1706) Combined With Chemotherapy for Previously Untreated Advanced or Metastatic Gastric or Gastroesophageal Junction Cancer NCT07315854Phase 21 site📍 Beijing Beijing Friendship Hospital · Tests: Iparomlimab and Tuvonralimab (QL1706), SOX Chemotherapy Pembrolizumab, Olaparib, Recurrent/Advanced Gastric and Gastro-esophageal Junction(GEJ) Cancer NCT04592211Phase 1, Phase 21 site📍 Seoul Yonsei University · Tests: olaparib+pembrolizumab+paclitaxel Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers NCT04221893NA2 sites📍 San Francisco📍 Walnut Creek University of California, San Francisco · Tests: Radiation Therapy (RT) First-line Treatment With RC48 Plus Sintilimab and S-1 in Advanced Gastric Cancer (RCTS2) NCT06730373Phase 220 sites📍 Zhengzhou📍 Binzhou📍 Dongying Qilu Hospital of Shandong University · Tests: Disitamab Vedotin, Sintilimab, S-1, Trastuzumab, Oxaliplatin Phase I/II Study of the Combination of Irinotecan and POF (POFI) and Tislelizumab NCT05319639Phase 1, Phase 21 site📍 Fuzhou Fujian Cancer Hospital · Tests: Oxaliplatin, Levo-Leucovorin, 5-fluorouracil, Paclitaxel, Irinotecan Assessing Iparomlimab and Tuvonralimab in Recurrent or Metastatic MSI-H/dMMR Gastric Cancer NCT07127822Phase 210 sites📍 Shijiazhuang📍 Harbin📍 Zhengzhou Peking University · Tests: Iparomlimab and Tuvonralimab, First line chemotherapy plus PD-1/PD-L1 antibody A Long-term Follow-up Study of Subjects Enrolled in Clinical Trials of Cadonilimab (AK104) NCT07547787n/a1 site📍 Beijing Akeso LM-302 and S-1 Plus Intraperitoneal Paclitaxel With or Without Cadonilimab for Claudin 18.2-positive Gastric or Gastroesophageal Junction Adenocarcinoma With Peritoneal Metastasis: a Prospective, Exploratory Study NCT07556640Phase 21 site📍 Shanghai Ruijin Hospital · Tests: LM-302, S-1, paclitaxel, LM-302, Cadonilimab, S-1, paclitaxel mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma NCT05677490Phase 3798 sites📍 Birmingham📍 Anchorage📍 Anchorage Alliance for Clinical Trials in Oncology · Tests: Fluorouracil, Leucovorin Calcium, Oxaliplatin, Irinotecan, Nivolumab Synergistic Effects of PD-1 Antibody and Chemotherapy/Targeted Therapy Followed by Surgery-centric Local Treatment in Patients With Limited-metastatic Gastric Cancer NCT06468280Phase 22 sites📍 Shanghai📍 Shanghai Shanghai Zhongshan Hospital · Tests: Local treatment (Surgical), PD-1 Monoclonal Antibody, XELOX/SOX Chemotherapy Regimen, Local Treatment (Non-surgical), T… Lenvatinib in Combination With Nivolumab Plus Chemotherapy in Metastatic Gastric Cancer Patients With Malignant Ascites NCT07149090Phase 1, Phase 21 site📍 Seoul Asan Medical Center · Tests: Lenvatinib Cytoreductive Gastrectomy After Systemic Therapy Versus Systemic Therapy Alone For Limited Metastasis Gastric Cancer NCT06768463NA1 site📍 Ho Chi Minh City University Medical Center Ho Chi Minh City (UMC) · Tests: Cytoreductive Gastrectomy Chemoradiotherapy and SHR-1701 in Patients With Unresectable Gastric Cancer NCT07689851Phase 23 sites📍 Shenzhen📍 Taiyuan📍 Beijing Cancer Institute and Hospital, Chinese Academy of Medical S… · Tests: COPOX, Radiotherapy, SHR-1701 Pharmacokinetic Study of Skeletal Muscle Area-based Paclitaxel Infusion in Patients With Cancer NCT05183126Phase 41 site📍 Ann Arbor University of Michigan Rogel Cancer Center · Tests: Paclitaxel, Paclitaxel Apatinib as the First-Line Therapy in Elderly Locally Advanced or Metastatic Gastric Cancer NCT03219593Phase 21 site📍 Bengbu The First Affiliated Hospital of Bengbu Medical University · Tests: Apatinib mesylate tablets Ramucirumab (Cyramza), Nal-IRI (ONIVYDE) and Trifluridine/Tipiracil (Lonsurf) in Second Line Metastatic Gastric Cancer . NCT05927857Phase 1, Phase 21 site📍 Taipei National Health Research Institutes, Taiwan · Tests: nal-IRI /Experimental, Ramucirumab /Experimental, Trifluridine/Tipiracil /Experimental Intravital Microscopy in Human Solid Tumors NCT03823144NA1 site📍 Jacksonville Mayo Clinic · Tests: Diagnostic Microscopy, Fluorescein Sodium Injection A Study to Evaluate the Safety,Pharmacokinetics,Pharmacodynamics,and Efficacy of TJ037130 in Adult Participants With Advanced Solid Tumors NCT07715747Phase 11 site📍 Shanghai TJ Biopharma Co., Ltd. · Tests: TJ037130 Identification of Therapeutic Targets in Metastatic Gastric Cancer NCT07551440n/a1 site📍 Hong Kong Chinese University of Hong Kong First-line EXL01 With Nivolumab and FOLFOX for PD-L1 CPS ≥5 Metastatic Gastric Cancer NCT06253611Phase 237 sites📍 Angers📍 Avignon📍 Besançon GERCOR - Multidisciplinary Oncology Cooperative Group · Tests: Nivolumab, FOLFOX regimen, EXL01 Concurrent Immunotherapy and Systemic Therapy With Stereotactic Body Radiation Therapy (SBRT) for Stage IV Cancers (COINSSS IV) NCT07770100Phase 21 site📍 Lexington Mark Bernard · Tests: Stereotactic Body Radiation Therapy (SBRT), Pembrolizumab, Nivolumab, Atezolizumab, Ipilimumab Givastomig Combined With Nivolumab and Chemotherapy in Adults With CLDN18.2 Positive Metastatic Gastric Cancer (GIVA-2) NCT07432295Phase 26 sites📍 Goodyear📍 Duarte📍 Boston I-Mab Biopharma US Limited · Tests: Givastomig, Nivolumab, 5Fluorouracil, Leucovorin, Oxaliplatin Ivonescimab in Comb. With FOLFOX in Advanced HER2 Neg. GEA NCT07070466Phase 22 sites📍 Santa Monica📍 Boston Massachusetts General Hospital · Tests: Ivonescimab, 5-Fluorouracil, Oxaliplatin, Leucovorin PD-1 Antibody Carilizumab Combined with Apatinib for Unresectable Stage III and IV DMMR Gastric Cancer NCT06792162Phase 21 site📍 Beijing Peking University Third Hospital · Tests: Carilizumab and Apatinib Liver Embolization Approaches for Tumor Management NCT05714124n/a1 site📍 Milan IRCCS San Raffaele · Tests: Embolization LM-108 in Combination With Toripalimab Versus Paclitaxel Injection for the Treatment of Subjects With CCR8-Positive Gastric and Gastroesophageal Junction Adenocarcinoma NCT07362186Phase 31 site📍 Beijing LaNova Medicines Limited · Tests: LM-108 in combination with Toripalimab, Paclitaxel injection intravenous infusion Ramucirumab and Trifluridine/Tipiracil or Paclitaxel for the Treatment of Patients With Previously Treated Advanced Gastric or Gastroesophageal Junction Cancer NCT04660760Phase 215 sites📍 Birmingham📍 Scottsdale📍 Tucson Academic and Community Cancer Research United · Tests: Paclitaxel, Quality-of-Life Assessment, Ramucirumab, Trifluridine and Tipiracil Hydrochloride PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer NCT04329494Phase 13 sites📍 Duarte📍 Jacksonville📍 Greenlawn City of Hope Medical Center · Tests: Biopsy, Cisplatin, Doxorubicin, Fluorouracil, Intraperitoneal Chemotherapy Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial NCT06203600Phase 2, Phase 3378 sites📍 Little Rock📍 Little Rock📍 Anaheim National Cancer Institute (NCI) · Tests: Biospecimen Collection, Computed Tomography, Magnetic Resonance Imaging, Nivolumab, Paclitaxel
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy